Jundishapur Journal of Microbiology

Published by: Kowsar

Hepatitis E Virus Infection Among Chronic Hemodialysis

Shokouh Shayanpour 1 , * and Fatemeh Hayati 1
Authors Information
1 Department of Internal Medicine, Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2016, 9 (3); e26645
  • Published Online: March 17, 2016
  • Article Type: Letter
  • Received: January 12, 2015
  • Revised: November 3, 2015
  • Accepted: January 4, 2016
  • DOI: 10.5812/jjm.26645

To Cite: Shayanpour S, Hayati F. Hepatitis E Virus Infection Among Chronic Hemodialysis, Jundishapur J Microbiol. 2016 ; 9(3):e26645. doi: 10.5812/jjm.26645.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Beladi Mousavi SS, Motemednia F, Beladi Mousavi M. Epidemiology of hepatitis e virus infection in patients on chronic hemodialysis. Jundishapur J Microbiol. 2014; 7(5)[DOI][PubMed]
  • 2. Beladi Mousavi SS, Sametzadeh M, Hayati F, Fatemi SM. Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography. Iran J Kidney Dis. 2010; 4(3): 223-6[PubMed]
  • 3. Beladi-Mousavi SS, Alemzadeh-Ansari MJ, Alemzadeh-Ansari MH, Beladi-Mousavi M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012; 6(6): 452-6[PubMed]
  • 4. Beladi-Mousavi SS, Beladi-Mousavi M, Hayati F, Talebzadeh M. Effect of intranasal DDAVP in prevention of hypotension during hemodialysis. Nefrologia. 2012; 32(1): 89-93[DOI][PubMed]
  • 5. DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis. 2003; 42(6): 1184-92[PubMed]
  • 6. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther. 2004; 20(11-12): 1271-7[DOI][PubMed]
  • 7. Feily A, Dormanesh B, Ghorbani AR, Moosavi Z, Kouchak M, Cheraghian B, et al. Efficacy of topical cromolyn sodium 4% on pruritus in uremic nephrogenic patients: a randomized double-blind study in 60 patients. Int J Clin Pharmacol Ther. 2012; 50(7): 510-3[PubMed]
  • 8. Rostami Z, Einollahi B, Lessan-Pezeshki M, Soleimani Najaf Abadi A, Mohammadi Kebar S, Shahbazian H, et al. Health-related quality of life in hemodialysis patients: an Iranian multi-center study. Nephrourol Mon. 2013; 5(4): 901-12[DOI][PubMed]
  • 9. Nemati E, Motalebi M. A Better Quality of Life in Hemodialysis Patients With Viral Hepatitis: Is it a Reality? Hepat Mon. 2013; 13(11)[DOI][PubMed]
  • 10. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008; 358(8): 811-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments